valsartan has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Asgharzadeh, F; Avan, A; Hashemzehi, M; Hassanian, SM; Khazaei, M; Mostafapour, A; Naghibzadeh, N | 1 |
Gold, KA; Gomez, DR; Levy, LB; Liao, Z; Nguyen, QN; O'Reilly, M; Wang, H; Xu, T; Zhuang, Y | 1 |
Huang, J; Huang, Y; Wang, T | 1 |
3 other study(ies) available for valsartan and Lung Neoplasms
Article | Year |
---|---|
Angiotensin II Receptor Antagonist, Valsartan, Has Beneficial Effect in Lung Metastasis of Colorectal Cancer Treated with Fluorouracil.
Topics: Angiotensin Receptor Antagonists; Animals; Colorectal Neoplasms; Fluorouracil; Humans; Lung Neoplasms; Valsartan | 2023 |
Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Non-Small-Cell Lung; Female; Humans; Imidazoles; Lisinopril; Lung; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Radiation Pneumonitis; Retrospective Studies; Risk; Sex Factors; Tetrazoles; Valine; Valsartan | 2013 |
Exfoliative esophagitis in a patient with metastatic renal cell carcinoma during sunitinib treatment.
Topics: Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Aspirin; Carcinoma, Renal Cell; Cyclooxygenase 2 Inhibitors; Esophagitis; Humans; Hypertension; Indoles; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Nephrectomy; Pyrroles; Sunitinib; Tetrazoles; Valine; Valsartan | 2013 |